These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24183076)

  • 21. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs.
    Tilley BC; Palesch YY; Kieburtz K; Ravina B; Huang P; Elm JJ; Shannon K; Wooten GF; Tanner CM; Goetz GC;
    Neurology; 2006 Mar; 66(5):628-33. PubMed ID: 16534099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Responsibilities of clinical pharmacology in the early phase of drug development].
    Kuhlmann J
    Med Klin (Munich); 2000 May; 95(1 Spec No):31-40. PubMed ID: 10851846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
    Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G
    Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seamless phase II/III designs.
    Stallard N; Todd S
    Stat Methods Med Res; 2011 Dec; 20(6):623-34. PubMed ID: 20724313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reading the research literature. Putting randomized clinical trials into practice. 2.
    Riegelman R
    Md Med; 2002; 3(2):52-6. PubMed ID: 12056230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.
    Urinary Incontinence Treatment Network (UITN)
    Contemp Clin Trials; 2007 Jan; 28(1):48-58. PubMed ID: 16919506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic analysis in phase III clinical cancer trials.
    Bennett CL; Armitage JL; Buchner D; Gulati S
    Cancer Invest; 1994; 12(3):336-42. PubMed ID: 8187012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical therapeutic trial of a new drug.
    MARSHALL EK; MERRELL M
    Bull Johns Hopkins Hosp; 1949 Sep; 85(3):221-30. PubMed ID: 18137208
    [No Abstract]   [Full Text] [Related]  

  • 33. Instrumental variable meta-analysis of aggregated randomized drug trial data for evaluating proposed target mechanisms.
    Ackley SF; Elahi F; Glymour MM
    BMJ; 2021 Feb; 372():n346. PubMed ID: 33632740
    [No Abstract]   [Full Text] [Related]  

  • 34. [Not Available].
    Dubray C; Maillere P; Spriet A;
    Therapie; 2007; 62(3):193-7. PubMed ID: 27393401
    [No Abstract]   [Full Text] [Related]  

  • 35. [Not Available].
    Berdaï D; Hotton JM; Lechat P;
    Therapie; 2010; 65(4):323-8. PubMed ID: 27393111
    [No Abstract]   [Full Text] [Related]  

  • 36. [Not Available].
    Bordet R; Lestage P; Onteniente B;
    Therapie; 2007; 62(6):463-72. PubMed ID: 27393679
    [No Abstract]   [Full Text] [Related]  

  • 37. [Not Available].
    Diebolt V; Pletan Y;
    Therapie; 2008; 63(4):291-5. PubMed ID: 27392546
    [No Abstract]   [Full Text] [Related]  

  • 38. [Not Available].
    Ousehal L; El Aouame A; Rachdy Z; Benkiran G
    Int Orthod; 2016 Jun; 14(2):195-205. PubMed ID: 27080596
    [No Abstract]   [Full Text] [Related]  

  • 39. [Not Available].
    Bahije L; Ennaji A; Benyahia H; Zaoui F
    Int Orthod; 2018 Sep; 16(3):409-424. PubMed ID: 30001981
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluating the efficacy of a new drug].
    Berbis J; Alessandrini M; Karsenty G; Auquier P
    Prog Urol; 2013 Nov; 23(15):1208-12. PubMed ID: 24183076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.